Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
View and Policy on Reduction of Investment Unit
Notice Concerning Changes in Directors
COSMOS Pharma, 0.1% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Increased Previous Year's Dividend by 5 Yen, This Fiscal Year to Increase Dividend by 5 Yen
Notice Concerning Distribution of Dividends of Surplus
Consolidated Financial Results for the Fiscal Year Ended May 31, 2025[Japanese GAAP]
COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 30%, Dec-Feb Ordinary Profit Increases by 40%
[Summary]Consolidated Financial Results for the Nine Months Ended February 28, 2025[Japanese GAAP]
(Correction)Consolidated Financial Results for the Six Months Ended November 30, 2024[Japanese GAAP]
COSMOS Pharma, First Half Ordinary Profit Increases by 26%
Consolidated Financial Results for the Six Months Ended November 30, 2024[Japanese GAAP]
COSMOS Pharmaceutical Corporation, June-August (1Q) Ordinary Profit Increases by 27%
Consolidated Financial Results for the Three Months Ended August 31, 2024[Japanese GAAP]